Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESPIRE 2: Ciprofloxacin DPI in Non-CF Bronchiectasis
NCT02106832Phase 3Completed
- Sponsor
- Bayer
- Start
- Apr 2014
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 25
01
Overview
A Phase 3 trial of ciprofloxacin in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Bayer. Started Apr 2014; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT02106832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02106832.